LAST PRICE - AT THE CLOSE
DRUG is DOWN -4% since the begininning of the year
DRUG is DOWN -10% BELOW 20 day SMA
DRUG is UP 45% ABOVE 200 day SMA
PROFITABLE: NO
EPS: $-0.443685
EARNINGS MOMENTUM: YES
0.53% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
![]() |
THE STOCK IS 39.5% AWAY FROM ALL-TIME HIGHS OF $123.75 |
![]() |
DRUG IS DOWN -4% SINCE THE BEGINNING OF THE YEAR |
![]() |
DRUG IS UP 62% OVER THE PAST 12 MONTHS |
![]() |
DRUG IS DOWN -14% OVER THE PAST 1 MONTH |
![]() |
8% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
![]() |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
![]() |
DRUG moved down N/A in the previous minute |
![]() |
DRUG is up N/A over the last hour |
![]() |
DRUG is up 100% over the last 5 days |
![]() |
DRUG is 100 above its 8 day SMA |
| $0.00 | DAY |
$0.00 |
| $73.61 | ![]() PREVIOUS DAY |
$78.34 |
| $72.08 | ![]() WEEK |
$81.00 |
| $72.08 | ![]() MONTH |
$92.00 |
| $23.18 | ![]() YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on
DRUG is mentioned N/A times in an average day on